Prostate Cancer and Prostatic Diseases Impact Factor, Indexing, Ranking

Prostate Cancer and Prostatic Diseases Impact Factor, Indexing, Ranking

Prostate Cancer and Prostatic Diseases (PCPD) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by Nature Publishing. The Print-ISSN to Prostate Cancer and Prostatic Diseases is 1365-7852 and its abbreviation is Prostate Cancer Prostatic Dis.


Prostate Cancer and Prostatic Diseases Aim and Scope

Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management. Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, male LUTS and prostatitis. Prostate Cancer and Prostatic Diseases publishes original research articles, reviews, topical comment and critical appraisals of scientific meetings and the latest books. The journal also contains a calendar of forthcoming scientific meetings. The Editors and a distinguished Editorial Board ensure that submitted articles receive fast and efficient attention and are refereed to the highest possible scientific standard. A fast track system is available for topical articles of particular significance.


Prostate Cancer and Prostatic Diseases Details


Journal title Prostate Cancer and Prostatic Diseases (PCPD)
Abbreviation Prostate Cancer Prostatic Dis
Print ISSN 1365-7852
Online ISSN 1476-5608
Publisher Name Nature Publishing
Editor-in-chief Cosimo De Nunzio, MD, PhD, Sapienza Universitร  di Roma, Italy
Subject Category Medicine
Access type Hybrid
Impact Factor 4.9
SJR 1.676
SNIP 1.335
Ranking 1765
CiteScore 8.9
H-Index 74
Status ๐ŸŸข Active
Impact Factor List 2024

Who we are? Clarification: Journals Insights - Your Open Access Ally